joining forces to
tackle serious disease

We partner with innovative pharma and biotech leaders to bring cutting-edge cell therapies to the clinic.

Together, we are creating breakthrough therapeutics to transform the lives of millions of people around the world. 

Partner with us

Aspect Biosystems & Novo Nordisk

Aspect Biosystems and Novo Nordisk are partnering to develop bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions inside the body with the aim of delivering a new class of truly disease-modifying treatments for diabetes and obesity.

The collaboration will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell differentiation and cell therapy development and manufacturing.

The collaboration will initially focus on developing bioprinted tissue therapeutics designed to maintain normal blood glucose levels without the need for immunosuppression, which may represent a transformative treatment for people living with type 1 diabetes.

Aspect's and Novo Nordisk's logos

Learn More